ORAI1 and cardiac hypertrophy: This, together with the recent data that trans-CA alleviated cardiac hypertrophy by improving tubulin detyrosination via regulating the SOCE signaling pathway and STIM1/Orai1 translocation, indicated that there were probably unknown mechanisms by which CA elicited epigenetic changes within the contractile proteins to display vasodilator abilities [134].